Heart failure: open trials in Kazakhstan

4 open trials have a site in Kazakhstan. Registry data; only the trial team decides who can take part.

NCT03549754
iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
Research · AstraZeneca
Aktobe · Almaty
Registry updated 2026-09-09
NCT06907017
CorWave LVAS FIH Study
Trial Treatment · CorWave
University Medical Center Heart Center, Astana
Registry updated 2026-08-03
NCT07631780
SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure
Trial Treatment · Nurgul Ablakimova
West Kazakhstan Marat Ospanov Medical University, Aktobe
Registry updated 2026-06-08
NCT06705023
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
Trial Treatment · Phase 2 · Ralf Rothoerl
National Scientific Medical Center, Astana
Registry updated 2024-12-03

This page is not medical advice. Talk to your doctor before contacting a trial.

iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases